Aktis Oncology, Inc. (AKTS)

NASDAQ: AKTS · Real-Time Price · USD

18.00

+0.11 (0.61%)

Apr 1, 2026, 10:23 AM EDT - Market open

Aktis Oncology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Apr '26 Apr 1, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	995	-	-	-	-
Enterprise Value	774	-	-	-	-
Debt / Equity Ratio	0.06	0.06	0.05	0.13	0.01
Debt / FCF Ratio	-	-	1.01	-	-
Net Debt / Equity Ratio	-1.15	-1.15	-1.16	-0.81	-0.97
Net Debt / EBITDA Ratio	2.98	2.98	5.65	2.51	6.57
Net Debt / FCF Ratio	2.92	2.92	-23.96	2.50	6.21
Asset Turnover	0.02	0.02	0.01	-	-
Quick Ratio	7.26	7.26	15.85	15.74	24.38
Current Ratio	7.37	7.37	15.98	16.07	25.12
Return on Equity (ROE)	-29.45%	-29.45%	-25.18%	-24.42%	-
Return on Assets (ROA)	-15.79%	-15.79%	-14.51%	-16.68%	-
Return on Capital Employed (ROCE)	-32.00%	-32.00%	-16.90%	-30.00%	-14.90%
Buyback Yield / Dilution	-	-	-14.46%	-18.90%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q